Search

Your search keyword '"Duval, Eric J."' showing total 11 results
Start Over Author "Duval, Eric J."
11 results on '"Duval, Eric J."'

1. COVID-19–Associated cardiac pathology at the postmortem evaluation: a collaborative systematic review

Author

Almamlouk, Raghed, Kashour, Tarek, Obeidat, Sawsan, Bois, Melanie C., Maleszewski, Joseph J., Omrani, Osama A., Tleyjeh, Rana, Berbari, Elie, Chakhachiro, Zaher, Zein-Sabatto, Bassel, Gerberi, Dana, Tleyjeh, Imad M., Paniz Mondolfi, Alberto E., Finn, Aloke V., Duarte-Neto, Amaro Nunes, Rapkiewicz, Amy V., Frustaci, Andrea, Keresztesi, Arthur-Atilla, Hanley, Brian, Märkl, Bruno, Lardi, Christelle, Bryce, Clare, Lindner, Diana, Aguiar, Diego, Westermann, Dirk, Stroberg, Edana, Duval, Eric J., Youd, Esther, Bulfamante, Gaetano Pietro, Salmon, Isabelle, Auer, Johann, Hirschbühl, Klaus, Absil, Lara, Barton, Lisa M., Ferraz da Silva, Luiz Fernando, Moore, Luiza, Dolhnikoff, Marisa, Lammens, Martin, Osborn, Michael, Remmelink, Myriam, Nascimento Saldiva, Paulo Hilario, Jorens, Philippe G., Craver, Randall, Aparecida de Almeida Monteiro, Renata, Scendoni, Roberto, Mukhopadhyay, Sanjay, Suzuki, Tadaki, Mauad, Thais, Fracasso, Tony, and Grimes, Zachary

Published
2022
Full Text
View/download PDF

4. SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice

Author

Dinnon, Kenneth H., primary, Leist, Sarah R., additional, Okuda, Kenichi, additional, Dang, Hong, additional, Fritch, Ethan J., additional, Gully, Kendra L., additional, De la Cruz, Gabriela, additional, Evangelista, Mia D., additional, Asakura, Takanori, additional, Gilmore, Rodney C., additional, Hawkins, Padraig, additional, Nakano, Satoko, additional, West, Ande, additional, Schäfer, Alexandra, additional, Gralinski, Lisa E., additional, Everman, Jamie L., additional, Sajuthi, Satria P., additional, Zweigart, Mark R., additional, Dong, Stephanie, additional, McBride, Jennifer, additional, Cooley, Michelle R., additional, Hines, Jesse B., additional, Love, Miriya K., additional, Groshong, Steve D., additional, VanSchoiack, Alison, additional, Phelan, Stefan J., additional, Liang, Yan, additional, Hether, Tyler, additional, Leon, Michael, additional, Zumwalt, Ross E., additional, Barton, Lisa M., additional, Duval, Eric J., additional, Mukhopadhyay, Sanjay, additional, Stroberg, Edana, additional, Borczuk, Alain, additional, Thorne, Leigh B., additional, Sakthivel, Muthu K., additional, Lee, Yueh Z., additional, Hagood, James S., additional, Mock, Jason R., additional, Seibold, Max A., additional, O’Neal, Wanda K., additional, Montgomery, Stephanie A., additional, Boucher, Richard C., additional, and Baric, Ralph S., additional

Published
2022
Full Text
View/download PDF

5. Targeting Doublecortin-Like Kinase 1 (DCLK1)-Regulated SARS-CoV-2 Pathogenesis in COVID-19

Author

Undi, Ram Babu, primary, Larabee, Jason L., additional, Filiberti, Adrian, additional, Ulahannan, Susanna, additional, Aravindan, Sheeja, additional, Stroberg, Edana, additional, Barton, Lisa M., additional, Duval, Eric J., additional, Mukhopadhyay, Sanjay, additional, Henthorn, James C., additional, Akins, Darrin, additional, Houchen, Courtney W., additional, Huycke, Mark M., additional, and Ali, Naushad, additional

Published
2022
Full Text
View/download PDF

6. A model of persistent post SARS-CoV-2 induced lung disease for target identification and testing of therapeutic strategies

Author

Dinnon, Kenneth H., primary, Leist, Sarah R., additional, Okuda, Kenichi, additional, Dang, Hong, additional, Fritch, Ethan J., additional, Gully, Kendra L., additional, De la Cruz, Gabriela, additional, Evangelista, Mia D., additional, Asakura, Takanori, additional, Gilmore, Rodney C., additional, Hawkins, Padraig, additional, Nakano, Satoko, additional, West, Ande, additional, Schäfer, Alexandra, additional, Gralinski, Lisa E., additional, Everman, Jamie L., additional, Sajuthi, Satria P., additional, Zweigart, Mark R., additional, Dong, Stephanie, additional, McBride, Jennifer, additional, Cooley, Michelle R., additional, Hines, Jesse B., additional, Love, Miriya K., additional, Groshong, Steve D., additional, VanSchoiack, Alison, additional, Phelan, Stefan J., additional, Liang, Yan, additional, Hether, Tyler, additional, Leon, Michael, additional, Zumwalt, Ross E., additional, Barton, Lisa M., additional, Duval, Eric J., additional, Mukhopadhyay, Sanjay, additional, Stroberg, Edana, additional, Borczuk, Alain, additional, Thorne, Leigh B., additional, Sakthivel, Muthu K., additional, Lee, Yueh Z., additional, Hagood, James S., additional, Mock, Jason R., additional, Seibold, Max A., additional, O’Neal, Wanda K., additional, Montgomery, Stephanie A., additional, Boucher, Richard C., additional, and Baric, Ralph S., additional

Published
2022
Full Text
View/download PDF

7. SARS-CoV-2 Immunohistochemistry In Placenta

Author

Rakheja, Dinesh, primary, Treat, Kristina, additional, Timmons, Charles F., additional, Carrillo, Deyssy, additional, Miller, Sara E., additional, Stroberg, Edana, additional, Barton, Lisa M., additional, Duval, Eric J., additional, and Mukhopadhyay, Sanjay, additional

Published
2021
Full Text
View/download PDF

8. SARS-CoV-2 Immunohistochemistry In Placenta.

Author

Rakheja, Dinesh, Treat, Kristina, Timmons, Charles F., Carrillo, Deyssy, Miller, Sara E., Stroberg, Edana, Barton, Lisa M., Duval, Eric J., and Mukhopadhyay, Sanjay

Subjects
SARS-CoV-2 Delta variant, SARS-CoV-2, PLACENTA, IMMUNOHISTOCHEMISTRY, PREGNANT women
Abstract

Compared to the parental SARS-CoV-2 virus, infections by the now dominant Delta variant of SARS-CoV-2 appear to be more common and more severe in pregnant women. The need for a robust, cheap, and quick method for diagnosing placental infection by SARS-CoV-2 has thus become more acute. Here, we describe a highly sensitive and specific immunohistochemical assay for SARS-CoV-2 nucleocapsid protein for routine use in placental pathology practice. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

9. COVID-19: A Multidisciplinary Review

Author

Chams, Nour, primary, Chams, Sana, additional, Badran, Reina, additional, Shams, Ali, additional, Araji, Abdallah, additional, Raad, Mohamad, additional, Mukhopadhyay, Sanjay, additional, Stroberg, Edana, additional, Duval, Eric J., additional, Barton, Lisa M., additional, and Hajj Hussein, Inaya, additional

Published
2020
Full Text
View/download PDF

11. A model of persistent post SARS-CoV-2 induced lung disease for target identification and testing of therapeutic strategies.

Author

Dinnon KH 3rd, Leist SR, Okuda K, Dang H, Fritch EJ, Gully KL, De la Cruz G, Evangelista MD, Asakura T, Gilmore RC, Hawkins P, Nakano S, West A, Schäfer A, Gralinski LE, Everman JL, Sajuthi SP, Zweigart MR, Dong S, McBride J, Cooley MR, Hines JB, Love MK, Groshong SD, VanSchoiack A, Phelan SJ, Liang Y, Hether T, Leon M, Zumwalt RE, Barton LM, Duval EJ, Mukhopadhyay S, Stroberg E, Borczuk A, Thorne LB, Sakthivel MK, Lee YZ, Hagood JS, Mock JR, Seibold MA, O'Neal WK, Montgomery SA, Boucher RC, and Baric RS

Abstract

COVID-19 survivors develop post-acute sequelae of SARS-CoV-2 (PASC), but the mechanistic basis of PASC-associated lung abnormalities suffers from a lack of longitudinal samples. Mouse-adapted SARS-CoV-2 MA10 produces an acute respiratory distress syndrome (ARDS) in mice similar to humans. To investigate PASC pathogenesis, studies of MA10-infected mice were extended from acute disease through clinical recovery. At 15-120 days post-virus clearance, histologic evaluation identified subpleural lesions containing collagen, proliferative fibroblasts, and chronic inflammation with tertiary lymphoid structures. Longitudinal spatial transcriptional profiling identified global reparative and fibrotic pathways dysregulated in diseased regions, similar to human COVID-19. Populations of alveolar intermediate cells, coupled with focal upregulation of pro-fibrotic markers, were identified in persistently diseased regions. Early intervention with antiviral EIDD-2801 reduced chronic disease, and early anti-fibrotic agent (nintedanib) intervention modified early disease severity. This murine model provides opportunities to identify pathways associated with persistent SARS-CoV-2 pulmonary disease and test countermeasures to ameliorate PASC.

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results